Evaluation of nanoparticle uptake in co-culture cancer models.

Co-culture models are currently bridging the gap between classical cultures and in vivo animal models. Exploring this novel approach unlocks the possibility to mimic the tumor microenvironment in vitro, through the establishment of cancer-stroma synergistic interactions. Notably, these organotypic m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elisabete C Costa, Vítor M Gaspar, João G Marques, Paula Coutinho, Ilídio J Correia
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/392f61d3d8854dba8a3f1a2c42467499
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:392f61d3d8854dba8a3f1a2c42467499
record_format dspace
spelling oai:doaj.org-article:392f61d3d8854dba8a3f1a2c424674992021-11-18T09:02:37ZEvaluation of nanoparticle uptake in co-culture cancer models.1932-620310.1371/journal.pone.0070072https://doaj.org/article/392f61d3d8854dba8a3f1a2c424674992013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23922909/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Co-culture models are currently bridging the gap between classical cultures and in vivo animal models. Exploring this novel approach unlocks the possibility to mimic the tumor microenvironment in vitro, through the establishment of cancer-stroma synergistic interactions. Notably, these organotypic models offer a perfect platform for the development and pre-clinical evaluation of candidate nanocarriers loaded with anti-tumoral drugs in a high throughput screening mode, with lower costs and absence of ethical issues. However, this evaluation was until now limited to co-culture systems established with precise cell ratios, not addressing the natural cell heterogeneity commonly found in different tumors. Therefore, herein the multifunctional nanocarriers efficiency was characterized in various fibroblast-MCF-7 co-culture systems containing different cell ratios, in order to unravel key design parameters that influence nanocarrier performance and the therapeutic outcome. The successful establishment of the co-culture models was confirmed by the tissue-like distribution of the different cells in culture. Nanoparticles incubation in the various co-culture systems reveals that these nanocarriers possess targeting specificity for cancer cells, indicating their suitability for being used in this illness therapy. Additionally, by using different co-culture ratios, different nanoparticle uptake profiles were obtained. These findings are of crucial importance for the future design and optimization of new drug delivery systems, since their real targeting capacity must be addressed in heterogenous cell populations, such as those found in tumors.Elisabete C CostaVítor M GasparJoão G MarquesPaula CoutinhoIlídio J CorreiaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e70072 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Elisabete C Costa
Vítor M Gaspar
João G Marques
Paula Coutinho
Ilídio J Correia
Evaluation of nanoparticle uptake in co-culture cancer models.
description Co-culture models are currently bridging the gap between classical cultures and in vivo animal models. Exploring this novel approach unlocks the possibility to mimic the tumor microenvironment in vitro, through the establishment of cancer-stroma synergistic interactions. Notably, these organotypic models offer a perfect platform for the development and pre-clinical evaluation of candidate nanocarriers loaded with anti-tumoral drugs in a high throughput screening mode, with lower costs and absence of ethical issues. However, this evaluation was until now limited to co-culture systems established with precise cell ratios, not addressing the natural cell heterogeneity commonly found in different tumors. Therefore, herein the multifunctional nanocarriers efficiency was characterized in various fibroblast-MCF-7 co-culture systems containing different cell ratios, in order to unravel key design parameters that influence nanocarrier performance and the therapeutic outcome. The successful establishment of the co-culture models was confirmed by the tissue-like distribution of the different cells in culture. Nanoparticles incubation in the various co-culture systems reveals that these nanocarriers possess targeting specificity for cancer cells, indicating their suitability for being used in this illness therapy. Additionally, by using different co-culture ratios, different nanoparticle uptake profiles were obtained. These findings are of crucial importance for the future design and optimization of new drug delivery systems, since their real targeting capacity must be addressed in heterogenous cell populations, such as those found in tumors.
format article
author Elisabete C Costa
Vítor M Gaspar
João G Marques
Paula Coutinho
Ilídio J Correia
author_facet Elisabete C Costa
Vítor M Gaspar
João G Marques
Paula Coutinho
Ilídio J Correia
author_sort Elisabete C Costa
title Evaluation of nanoparticle uptake in co-culture cancer models.
title_short Evaluation of nanoparticle uptake in co-culture cancer models.
title_full Evaluation of nanoparticle uptake in co-culture cancer models.
title_fullStr Evaluation of nanoparticle uptake in co-culture cancer models.
title_full_unstemmed Evaluation of nanoparticle uptake in co-culture cancer models.
title_sort evaluation of nanoparticle uptake in co-culture cancer models.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/392f61d3d8854dba8a3f1a2c42467499
work_keys_str_mv AT elisabeteccosta evaluationofnanoparticleuptakeincoculturecancermodels
AT vitormgaspar evaluationofnanoparticleuptakeincoculturecancermodels
AT joaogmarques evaluationofnanoparticleuptakeincoculturecancermodels
AT paulacoutinho evaluationofnanoparticleuptakeincoculturecancermodels
AT ilidiojcorreia evaluationofnanoparticleuptakeincoculturecancermodels
_version_ 1718420956992503808